| Name | Title | Contact Details |
|---|
Total Resources Intl is a Walnut, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Driven to raise the standard of care and improve the lives of patients with brain tumors, a team of brain tumor specialists formed GT Medical Technologies. FDA-cleared GammaTile Therapy is a Surgically Targeted Radiation Therapy (STaRT) for patients undergoing brain tumor removal surgery of newly diagnosed malignant and recurrent brain tumors. This "one-and-done" treatment eliminates the need for one to six weeks of daily external beam radiation therapy, allowing patients to go about their daily lives without the burden of additional trips to the hospital or clinic for ongoing treatment. Since its full market release in the United States in March 2020, GammaTile has been offered in more than 95 hospitals, with more centers being added each month.
Synoptics was formed in 1985 by three researchers from the University of Cambridge who had developed a `tool box` for the generation of image analysis applications. The business grew quickly with many major companies using Synoptics to help develop imaging solutions across a wide range of applications. With a growing knowledge of CCD camera technology, frame grabbing and image capture techniques the company was able to enhance its skill sets within digital imaging.
Stethographics is a Westborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
C. R. Bard is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialties. Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. Bard pioneered the development of single-patient-use medical products for hospital procedures; today Bard is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall health care costs.